| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/16/2009 | EP2099817A2 Ob-fold used as scaffold for engineering new specific binders |
| 09/16/2009 | EP2099490A1 New drug for inhibiting, preventing or treatment of rheumatoid arthritis |
| 09/16/2009 | EP2099414A2 Human antibodies that bind human il-12 and methods for producing |
| 09/16/2009 | EP1638599B1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 09/16/2009 | EP1519748B1 Microparticle with cd28-specific monoclonal antibodies |
| 09/16/2009 | EP1414948B1 Inhibition of apoptosis process and improvement of cell performance |
| 09/16/2009 | EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses |
| 09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | EP1002084B1 Mammalian cytokine: interleukin-b30 and related reagents |
| 09/16/2009 | CN101535344A Novel antiproliferation antibodies |
| 09/16/2009 | CN101535343A Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 09/16/2009 | CN101531718A Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof |
| 09/16/2009 | CN101531717A Anti-Alzheimer disease monoclonal antibody and application thereof |
| 09/16/2009 | CN101531716A Alpha<sl>-casein and kappa-casein specific antibody, kit and test paper strip |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN100541198C Methods for diagnosis and therapy of cancer and composition useful therein |
| 09/16/2009 | CN100540053C New clinical parameters for determining hematologic toxicity proior to radioimmunotherapy |
| 09/15/2009 | US7589182 Capable of detecting and isolating polypeptides that are tyrosine-sulfated; specific for a sulfated tyrosine antigenic determinant in a sulfotyrosine-containing polypeptide |
| 09/15/2009 | US7589181 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 09/15/2009 | US7589180 Specific binding proteins and uses thereof |
| 09/15/2009 | US7589179 Modified interleukin-7 (IL-7) polypeptides with reduced T-cell response |
| 09/15/2009 | US7589175 Human OX2 receptors |
| 09/15/2009 | US7589173 Tumor marker protein that can be used to prepare antibodies that bind to the protein; used to reduce or eliminate metastasis by cancer cells that produce the tumor marker protein |
| 09/15/2009 | US7589074 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 09/15/2009 | US7588925 Isolated from Aspergillus niger; used in industrial processes and methods of diagnosing fungal infections; reducing phospholipid content of an edible oil; baked goods |
| 09/15/2009 | US7588916 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors |
| 09/15/2009 | US7588900 Mammalian sweet and amino acid heterodimeric taste receptors |
| 09/15/2009 | US7588771 anticancer treatment by administering a recombinant vaccina virus of a modified TK thymidine kinase and HA hemagglutinin gene; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588767 Recombinant vaccina virus of a modified TK and HA gene and optionally a modified F3 gene or locus; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588762 Streptoccal inhibitor of complement-mediated lysis, protein SIC |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2366514C Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 09/15/2009 | CA2348828C Genomic and complete cdna sequences of apm1 and biallelic markers thereof |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/14/2009 | CA2640954A1 Hepatitis c virus inhibitors |
| 09/11/2009 | WO2009111729A1 Anti-dnp antibodies and methods of use |
| 09/11/2009 | WO2009111707A1 Combination therapy with c-met and her antagonists |
| 09/11/2009 | WO2009111508A2 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | WO2009111085A1 Use of cd23 antibodies to treat malignancies in patients with poor prognosis |
| 09/11/2009 | WO2009110918A1 Anti-properdin antibodies |
| 09/11/2009 | WO2009110383A1 Method for screening of therapeutic agent for cancer |
| 09/11/2009 | WO2009109911A1 Methods of treating chronic pain |
| 09/11/2009 | WO2009109908A1 Methods of treating inflammatory pain |
| 09/11/2009 | WO2009109860A2 Mutant forms of chlamydia htra |
| 09/11/2009 | WO2009109635A2 Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 09/11/2009 | WO2009109584A1 ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX |
| 09/11/2009 | WO2009109572A2 Monovalent phage display of single variable domains |
| 09/11/2009 | WO2009109368A1 Identification of antigen- or ligand-specific binding proteins |
| 09/11/2009 | WO2009109363A1 Composition for treating or preventing streptococcal infections |
| 09/11/2009 | WO2009088928A3 Libraries, arrays and their uses for targeted affinity enhancement |
| 09/11/2009 | WO2009075836A3 Rap variants for drug delivery |
| 09/11/2009 | WO2009067642A3 Removing polypeptides from stool |
| 09/11/2009 | WO2009055074A3 Erbb2 binding proteins and use thereof |
| 09/11/2009 | WO2006108658A3 Process for the production of monoclonal antibodies using chimeric vlps |
| 09/11/2009 | WO2004039952A3 Methods of use for novel human polypeptides encoded by polynucleotides |
| 09/11/2009 | CA2717803A1 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | CA2717736A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | CA2717015A1 Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 09/11/2009 | CA2716799A1 Methods of treating inflammatory pain |
| 09/11/2009 | CA2716670A1 Combination therapy with c-met and her antagonists |
| 09/11/2009 | CA2716424A1 Methods of treating chronic pain |
| 09/11/2009 | CA2715341A1 Identification of antigen- or ligand-specific binding proteins |
| 09/10/2009 | US20090229009 Polynucleotides and methods for improving plants |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090228994 Antibody Composition-Producing Cell |
| 09/10/2009 | US20090227778 Stable cell lines expressing herg1a and herg1b |
| 09/10/2009 | US20090227777 Monoclonal antibody for hippuric acid antigen |
| 09/10/2009 | US20090227776 Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227468 Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes |
| 09/10/2009 | US20090227021 Purified mammalian ctla-8 antigens and related reagents |
| 09/10/2009 | US20090227014 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/10/2009 | US20090227012 Nucleotide sequences coding modified immunoglobulin for use in prevention and treatment of cancer and/or inflammatory disease |
| 09/10/2009 | US20090226942 Modified aerolysin and methods of use for treating lung cancer |
| 09/10/2009 | US20090226935 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 09/10/2009 | US20090226932 Novel G Protein-Coupled Receptor |
| 09/10/2009 | US20090226930 Beta cell antigen |
| 09/10/2009 | US20090226929 Titinic ion channel, compositions and methods of use |
| 09/10/2009 | US20090226918 Gene overexpressed in cancer |
| 09/10/2009 | US20090226897 Saposin d and fam3c are biomarkers for alzheimer's disease |
| 09/10/2009 | US20090226480 Streptococcus uberis adhesion molecule |
| 09/10/2009 | US20090226478 Early detection of flaviviruses using the NS1 glycoprotein |
| 09/10/2009 | US20090226473 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226465 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 09/10/2009 | US20090226461 IL1-Beta Binding Antibodies and Fragments thereof |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226458 Screening For Anti-Cancer Compounds Using Netrin-1 Activity |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226454 Antibodies against a peptide epitope of apoliporotein b |
| 09/10/2009 | US20090226453 Sphingosine 1-phosphate antagonism |